The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


Reply to the letter to the editor regarding the article “Prediabetes and its impact on clinical outcome after coronary intervention in a broad patient population”

EuroIntervention 2019;14:e1621-e1622 published online e-edition February 2019. DOI: 10.4244/EIJ-D-18-00235R

1. Thoraxcentrum Twente, Medisch Spectrum Twente, Enschede, the Netherlands; 2. Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom; 3. Health Technology and Services Research, MIRA- Institute of Technical Medicine and Biomedical Technology, University of Twente, Enschede, the Netherlands

We welcome the opportunity of responding to Dr Chattopadhyay et al and elaborating on the rationale for using HbA1c and fasting plasma glucose (FPG) assessments in this study1.

HbA1c has increasingly been used as a diagnostic test for diabetes mellitus (DM) and a screening test to identify subjects at high risk of DM2. HbA1c measurement can be performed at any time of the day and does not require the patient to be fasting, making it an appropriate test in routine clinical settings. Although the oral glucose tolerance test (OGTT) is said to be more sensitive ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Amplatzer Muscular Ventricular Septal Occluder in transcatheter occlusion of the left main coronary artery in a patient with a huge aneurysm secondary to Kawasaki Disease